Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | CTSD | P07339 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13687323 | 0.80 | MAPT (0.48) | KDM4EMAPTPOLBHTTALDH1A1 | |
| SCHEMBL2825299 | 0.76 | MAPT (0.61) | KDM4EMAPTPOLBHTTALDH1A1 | |
| SCHEMBL16367153 | 0.75 | ALDH1A1 (0.42) | KDM4EPOLBALDH1A1CHRM5CHRM3 | |
| SCHEMBL8613123 | 0.75 | SIGMAR1 (0.51) | KDM4EMAPTPOLBHTTALDH1A1 | |
| SCHEMBL13051492 | 0.74 | HSD17B10 (0.48) | KDM4EPOLBCHRM5CHRM3SMN1; SMN2 | |
| SCHEMBL4089872 | 0.74 | MAPT (0.64) | KDM4EMAPTPOLBALDH1A1SMN1; SMN2 | |
| SCHEMBL4080193 | 0.74 | MAPT (0.64) | KDM4EMAPTPOLBALDH1A1SMN1; SMN2 | |
| SCHEMBL19311997 | 0.73 | ALDH1A1 (0.47) | KDM4EPOLBALDH1A1CHRM5CHRM3 | |
| SCHEMBL24003473 | 0.72 | KDM4E (0.52) | KDM4EMAPTPOLBHTTALDH1A1 | |
| SCHEMBL20881929 | 0.72 | HSD17B10 (0.47) | KDM4EMAPTPOLBHTTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11794161-B1 | Reduced permeability microcapsules | TRUCAPSOL, LLC (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230330615-A1 | MICROCAPSULES COMPRISING NATURAL MATERIALS | ALTER DOMUS (US) LLC | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11794161-B1 | Reduced permeability microcapsules | CHMP4B, NSF, ACR | KDM4E 2666/4885MAPT 1409/4885POLB 3103/4885 |
| US-20230330615-A1 | MICROCAPSULES COMPRISING NATURAL MATERIALS | RCC1, SAMM50, LIPA | KDM4E 3016/4885MAPT 1394/4885POLB 2567/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.